Annals of Antivirals and Antiretrovirals Submit Manuscript

    Introduction

    • Volume/IssueClick here
    • Review ProcessDouble Blind
      • Publication lead time3 - 4 weeks
      • Indexing statusYes; Purview
      • Manuscript Processing ChargesClick here
      • Submission ChargesNo
      • Waiver policy for APCYes
      • Language of Full TextEnglish
      • Full-text formats availablePDF, HTML
    • Show +
    • Articles digitally archived in PORTICO
    • Permanent article identifierDOI (Digital Object Identifier) We provide DOI to all published papers to facilitate higher citation and classification of articles.
      Peertechz Publisher ID: 10.17352
    • Type of LicenseCreative Commons
      • Open AccessYes; Policy
      • Does the author retain unrestricted copyright?Yes
      • Does the author retain publishing rights?Yes
    • Show +

    Editor-in-Chief

    Peter Lloyd Nara

    Peter Lloyd Nara
    Private Compnay- Biological Mimetics, Inc., USA
    Email: [email protected]
    Tel: 301-514-4917; 301-51

    Skype: peter.nara-bmi

    More Info.

    Editorial Board

    Larance Ronsard
    Harvard Medical School
    USA
    AAA

    Research Interest: Identification of Immunomodulatory, Effects of a Drug in Rhesus Monkey Model, Canonical Signaling Pathways.


    More Info.
    Xiaofei Cheng
    Associated Professor
    Hangzhou Normal University
    PR China
    AAA

    Research Interest: Plant Viruses; Virus-Host Interaction; Viral Infection; Anti-Viral Research


    More Info.
    M Obulesu
    Department of Materials Science
    University of Tsukuba
    Japan
    AAA

    Research Interest: Alzheimer's Disease, Nanoparticles, Hydrogels, Biomaterials

    More Info.
    Parmit Singh
    National Institute of Child Health and Human Development National Institutes of Health
    USA
    AAA

    Research Interest: HIV-1, Retrovirology, Retroviruses, Splicing, Genetics and Molecular Biology, Chromatin Biology, NGS, Bioinformatics, Geneom Analysis.


    More Info.
    Angel S. Galabov
    Professor
    Virology
    The Stephan Angeloff Institute of Microbiology
    Bulgaria
    AAA

    Publications List:

    1. Galabov, Angel S. (2017): On the action of N1,N1-anhydro-bis(β-hydroxyethyl)biguanide hydrochloride (abitylguanide, moroxidine, ABOB) versus RNA viruses. – Acta Microbiologica Bulgarica 32 (4), 221-223.

     

    2. Petrov, N., A. S. Galabov (2017): Posttranscriptional gene silencing as a tool to control Coxsackievirus infections. – In: Microbiology for a Better Health and Industry (70th Years Jubilee of the Stephan Angeloff  Institute of Microbiology, BAS) (H. Najdenski, Ed.),Sofia,  pp. 185-193.

     

    3. Grozdanov, P., L. Simeonova, I. Nikolova, A. S. Galabov (2017): Detection of oral human papilloma viruses (HPV). - In: Microbiology for a Better Health and Industry (70th Years Jubilee of the Stephan Angeloff  Institute of Microbiology, BAS) (H. Najdenski, Ed.),Sofia,  pp. 194-198.

     

    4. Nikolaeva-Glomb, L., L. Mukova, N. Nikolova, V. Kussovski, L. Doumanova,

    V. Mantareva, I. Angelov, D. Wöhrle, A. S. Galabov (2017): Photodynamic effect of some

    phthalocyanines on enveloped and naked viruses. –Acta Virologica 61 doi:10, 4149/av _201_313.

     

    5. Galabov, Angel S., Vesselina Vassileva, Vera Karabasheva (2017): Inhibitory effect of abitylguanide on adenovirus replication. –Drug Research  2017-02-1359/24.5.2017/MPS.

     

    6. Angelova, A. L., M. Witzens-Harig, A. S. Galabov, J. Rommelaere (2017): The oncolytic virotherapy era in cancer management: prospects of applying H-1 parvovirus to treat blood and solid cancers. -  Frontiers in Oncology, https://doi.org/10.3389/ fonc.2017.00093.

    7.  Arita, M., G. Dobrikov, G. Pürstinger, A. S. Galabov (2017): Allosteric regulation of phosphatidylinositol 4-kinase III beta by an anti-picornavirus compound MDL-860. – ACS Infect. Dis. DOI: 10.1021/acsinfecdis.7b0005.3

     

    8. Galabov, Angel. S., Lucia Mukova, Yuriy P. Abashev, Lilia Wassilewa, Petko Tzvetkov, Vassil Minkov, Igor F. Barinskiy, Sergey Ouzounov, Dorotea Sidzhakova (2017): Cycluridine: A novel antiviral effective against flaviviruses. – Antivir. Chem. Chemother. 25: 58-67.

     

    9.  Гълъбов, Ангел (2017): Популационна генетика на българите. – Форум, 2(2017): 40-46.

     

    10. Dobrikov, G. M., I. Slavchev, I. Nikolova, A. Stoyanova, N. Nikolova, L. Mukova, R. Nikolova, B. Shivachev, Angel S. Galabov (2017): Synthesis and anti-enterovirus activity of new analogues of MDL-860-633. –  Bioorganic & Medicinal Chemistry Letters 27: 4540-4543.

     

    11. Karachanak-Yankova, Sena, Desislava Nesheva, Draga Toncheva, Angel S. Galabov (2017): The uniparental genetic landscape of modern Slavic speaking populations. –

    Advances in Anthropology 7(4): ID: 1590624.

     

    12. Galabov, Angel S., Lubomira Nikolaeva-Glomb, Lucia Mukova, Emilia Ajvazova, Mimi Remichkova, Irina Georgieva, Monika Cseuz (2017): Large scale antiviral activity screening of a triple mixed herbal extract.- Intern. J. Herbal Medicine 5(5): 169-176.

    13.  Нешева, Д., С. Карачанак-Янкова, А. Гълъбов, Д. Тончева (2017): Основни проблеми и решения при работа с древни кости и зъби. – Списание на БАН 6(2017): 56-59.

     

    14. Vilhelmova-Ilieva, N., A. S. Galabov (2017): Tannins as natural helpers in reinforcement of human health. – Acta Microbiol. Bulg. 33 (3), 105-110.

     

    15. Vilhelmova-Ilieva, N., S. Quideau, R. Jacquet, A. S. Galabov (2018): Castalagin: some aspects of the mode of anti-herpes viral activity. – Annals of Antivirals @ Antiretrovirals  doi.org/10.17352/aaa

     

    16. Chayrov, R. L., E. K. Stylos, M. V. Chatziathanasiadou, K. N. Chuchkov, A. I. Tencheva, A. D. Kostagianni, T. S. Milkova, А. L. Angelova, A. S. Galabov, S. A. Shishkov, D. G. Todorov, A. G. Tzakos, I. G. Stankova (2018): Tailoring  acyclovir prodrugs with enhanced antiviral activity: rational design, synthesis, human plasma stability and in vitro evaluation. - Amino Acids, doi.org/10.1007/s00726-018-2590-y

     

    17. Karaivanov, S., M. Manchev, A. S. Galabov (2018): Prophylactic effect of abitylguanide in nuclear polyedrosis of silkwarm.- Intern. J. Agriculture, Environment & Bioresearch 3(03): 163-175. IF=2.33.

     

    18. Mileva, M., A. S. Galabov (2018): Vitamin E and Influenza virus infection.-

    In: Vitamin E (ed. Morales-Gonzales), IntechOpen, London, pp. 67-82.

     

    19. Galabov, A, S. (2018): Chemotherapy of Adenovirus Infections.-

    In: Adenoviruses (ed. Y. A. Desheva), IntechOpen, London, pp. 123-28.

     

    20. Galabov, A. S.,  L. NIkolaeva-Glomb, A. Stoyanova, I. Nikolova, N. Petrov, N.-Vilhelmova-Ilieva, R. Vassileva-Pencheva, Z, Salama (2018): Testing of silans for antiviral activity.- Acta Microbiol. Bulg. 34(3): 134-148.

     

    21. Simeonova, L., L. Mukova, G. Gegova, A. S. Galabov, S. van der Werf (2018): Susceptibility to neurominidase inhiubitors and M2 blockers of seasonal influenza strains isolated in Bulgaria 2004-2007.- Acta Microbiol. Bulg. 34(4): 209-219.

     

    22. Vilhelmova-Ilieva, N., R. Jacquet, D. Deffieux, L. Pouysegu, T. Sylla, S. Chassaing,

    I. Nikolova, S. Quideau, A. S. Galabov (2019): Anti-herpes simplex virus type 1 activity of

    specially selected group of tannins. – Drug Res. 69: 374-381.

     

    23. Гълъбов, А. С. (2019): Вирусологията – моят път (второ допълнено издание).-

    София, Прес Продъкт Лайн, издател (ISBN 978-619-7177-04-6), 230 стр.

     

    24. Modi, A., D. Nesheva, S. Sarno, S. Vai, S. Karachanak-Yankova, D. Luiselli, E. Pilli, M. Lari, C. Vergata, Y. Yordanov, D. Dimitrova, P. Kalcev, O. Antonova, S. Hadjidekova, A. Galabov, D. Toncheva, D. Caramelli (2019): Ancient human mitochondrial genomes from Bronze Age Bulgaria: new insights into the genetic history of Thracians. – Scientific Reports 9:5412 [htttps://doi.org/10.1038/s41598-019-41945-0

     

    25. Nikolova I. I. Slavchev, M. Ravutsov, M. Danglov, Y. Nikolova,  I. Zagranyarska, A. Stoyanova, N. Nikolova, L. Mukova, P. Grozdanov, R. Nikolova, B. Shivachev, V. E. Kuz’min, L. N. Ognichenko, A. S. Galabov, G. M. Dobrikov (2019): Anti-enteroviral activity of new MDL-860 analogues: synthesis, in vitro/in vivo studies and QSAR analysis. –

    Bioorg. Chem. 85: 487-497.

     

    26. Mastikova,  M., A. S. Galabov, A. A. Karparov, P. Dosseva-Rnevska (2019):

    Antiviral activity od dipyridamole in experimental viral infections in mice.- Acta Microbiol. Bulg. 35: 46-52.

     

    27. Petrov, N., M. Stoyanova, A. Galabov (2019): Inhibition of coxsackievirus b3 cardiotropic strain Woodruff replication by silencing essential viral genes.- Biotechn. Biotechnol. Equip. 33: 1582-1589.

     

    28. Stankova, I., K. Chuchkov, R. Chayrov, L. Mukova, A. Galabov, D. Marinkova,  D. L. Danalev (2019): Adamantаne derivatives containing thiazole moiety – synthesis, antiviral and antibacterial activity.- J. Peptide Res. & Therapeutics, DOI: 10.1007/s10989-019-09983-4.

     

    29. Vilhelmova-Ilieva, N., A. S. Galabov, M. Mileva 92019): Tannins as Antiviral Agents.-

    In: Tannins, IntechOpen, London.

     

    30. Grozdanov, P., M.-L. Joffret, A. Stoyanova, , P. Polston, I. Nikolova, F. Delpeyroux,

    AS. Galabov (2020): Genome analysis of coxsackievirus B1 isolates during the consecutive alternating administration course of  triple antiviral combination in newborn mice. –

    Antivir. Chem. Chemother. 28: 1-6.

     

    31. Mileva, M., A. Dimitrova, D. Krastev, A. Alexandrova, E. Tsvetanova, A. Georgieva,   A. Galabov (2020):  Oseltamivir and S-adenosyl-L-methionine combination as effective therapeutic strategy for suppression of oxidative damage in lung  caused by influenza virus infection in mice. –  Drug Res. 70: 273-279.

     

    32. Galabov, A. S., S. A. Galabov (2020): Antivirals effective toward SARS-CoV-2. –

    Acta Microb. Bulg. 36: 3-8.

     

    33. Vilhelmova, N., L. Simeonova, N. Nikolov, E. Pavlova, Z. Gospodinova, G. Antov, A. Galabov, I. Nikolova (2020): Antiviral, cytotoxic and antioxidant effects of Tanacetum vulgare L. crude extract in vitro. – Folia medica 62: 172-179.

     

    34. Гълъбов, А. С. (2020): COVID-19. – Наука 30 (1): 12-16.

      

    35. Mukova, L., AS. Galabov (2020): Study of urotropin for virucidal action toward  HSV-1 and HSV-2. – Acta Microb. Bulg. 36: 68-69.

    .

    36. Vilhelmova-Ilieva, N., I. Sirakov, R. Jacquet, D. Deffieux, S. Quideau, A. S. Galabov(2020): Antiviral activities of ellagitannins against bovine herpesvirus 1, suid alphaherpesvirus 1 and caprine herpesvirus 1. – J. Vet. Med. & Animal Health 12(4): 139-143.

     

    37. Stoyanova, A., A. S. Galabov (2020): Effect of consecutive alternating administration of a triple combination of anti-enteroviral compounds in mice infected with Coxsackievirus B3.- Pathogens and Disease 78, ftaa065.

     

    38. Mileva, M., A. Dimitrova, D. Krastev, A, Alexandrova, E. Tsvetanova,  A. Galabov (2020): Oseltamivir and 5-adenosyl-L-methionine combination as effective therapeutic strategy for suppression of oxidative damage in lung caused by influenza virus infection in mice. – Drug Res. 70: 273-279.

      

    39. Galabov, A. S. (2021): Dipyridamole as an interferon inducer.  – Acta Microbiologica Bulgarica 37: 3-9.

     

    40. Vilhelmova-Ilieva, N., K. Idakieva, L. Doumanova, A. S. Galabov (2021): Antiviral Activity of Rapana thomasiana hemocyanin against bovine rotavirus.- Acta Microbiologica Bulgarica 37: 46-50.

     

    41. Stoyanova, A., A. S. Galabov (2021a): Consecutive alternating adminiatration as effective anti-coxsackievitus B3 in vivo .- Archives of Virology 10.1007/s00705-021-05057-3.

     

    42. Galabov, A. S. (2021): Dipyridamole as an Antiviral Agent.  –  In:  Recent Progress in Microbiology and Biotechnology vol. 5 ( Makky, E. A., ed.) Chapter 6. Book Publisher International, Hoogly . India, United Kingdom, pp.67-77. DOI: 10.9734/bpi/rpmb/v5/1942F.

     

    43. Galabov, A. S., A. Stoyanova (2021): On the Effective Antiviral Treatment of Enterovirus Infections. –  In:  Recent Progress in Microbiology and Biotechnology vol. 5 ( Makky, E. A., ed.)  Chapter 10. Book Publisher International, Hoogly.  India, United Kingdom, pp. 101-116, DOI: 10.9734/bpi/rpmb/v5/1929F.

     

    44. Dimitrova, A., M. Mileva, D. Krastev, I. KIndekov, A. S. Galabov (2021): Multiorgan pathological changes caused by experimental influenza virus infection in mice. –  C. r. Acad. Bulg. Sci. 74: 1479-1487.

     

    45. Stoyanova, A., A. S. Galabov (2022): Effect of double combinations of enterovirus replication inhibitors towards coxsackie B viruses. – Acta virologica 65: 411-419.

     

    46. Тончева, Д., A. Гълъбов, Д. Нешева (2021): Характеристика на антропогенетичния произход на българите. - In: България и Македония. История и политика. Първа част (Ред. Бианка Пашкова), Издателство: Македонски научен институт/Тангра, ИК, София, стр. 127-148.

     

    47. Galabov, A. S., A. Stoyanova (2022): Consecutive alternating administration of triple combination of virus inhibitors as a new therapy of enterovirus infection. – In: Petrova, P., Angelova, M., Krumova, E., Kabaivanova, L. (eds.).Modern Microbiology: a Challenge for Improving the Quality of Life. 75th Years Anniversary of the Stephan Angeloff  Institute of Microbiology. Publ. House “Farago”, Sofia. pp. 179-191.

     

    48.. Vihelmova-Ilieva, N., I. Nikolova, M. Mileva, Z. Petrova, P. Grozdanov, N. Nikolova, M. Tre[pechova, A.  S. Galabov (2022): Natural products inhibitors of human and animal herpes viruses. – In: Petrova, P., Angelova, M., Krumova, E., Kabaivanova, L. (eds.).Modern Microbiology: a Challenge for Improving the Quality of Life. 75th Years Anniversary of the Stephan Angeloff  Institute of Microbiology. Publ. House “Farago”, Sofia. pp. 201-211.

     

    49. Mileva, M., D. Krastev, E. Tsvetanova, A. Georgieva, A. Alexandrova, A. Dimitrova, L. Mukova. A. S. Galabov (2022): Oseltamivir and S-adenosyl-L-methionine combination as an effective therapeutic strategy for suppression of oxidative damages caused by influenza virus infect ion in mice.- In: Petrova, P., Angelova, M., Krumova, E., Kabaivanova, L. (eds.).Modern Microbiology: a Challenge for Improving the Quality of Life. 75th Years Anniversary of the Stephan Angeloff  Institute of Microbiology. Publ. House “Farago”, Sofia. pp. 220-229.

     

    50. Hristova, N., А. Stoyanova, S. A. Galabov, А. S. Galabov (2022): Preparation of HSV-1 and HSV-2 strains with increased virulence. – Acta Microbiologica Bulgarica 18: 40-47.

     

    51.. Petrov, N., M. Stoyanova, A. Stoyanova, I. Nikolova, P. Grozdanov, A. Galabov (2022):

    Gene silencing of VP1 gene of coxsackievirus B3 neurotropic strain Nancy by dsRNAs and siRNAs. – Biotechnol. Biotechnol. Eq. 36: 353-361.

        

    52. Гълъбов, А. С. (2022): Есберитокс и неговото приложение в клиничната практика.- Medinfo 2022/10: 28-32.

     

    53. Nikolova, I., I. Slavchev, I. Zagranyarska, N. Nikolova, N. Vilhelmova, A. Stoyanova, P. Grozdanov, L. Mukova, A. S. Galabov, I. Lessigiarska, I. Tsakovska, G. Dobrikov (2022):

    Synthesis and QSAR analysis of diarylethers and their analogues as potential antiviral agents.- Chem. Med. Chem., in press.

     

    54. Hristova, N., A. S. Galabov (2022): Genus Simplexvirus: clsification, morphology and genom organization. –  Acta Microbiologica Bulgarica 38 (4): 280-288.

     

    55. Гълъбов, А. С., Х. Найденски (2022): Луи Пастьор: 200 години от рождението.-

    Списание на Българската Академия на науките. 2022/6: 57-61.

     

    56. Mileva, M., A. Dimitrova-Koleva, E. Tsvetanova, D. Krastev, A. Georgieva, A. Alexandrova, A. S. Galabov (2022): Mitigation of  the oxidative damage in liver caused by influenza virus infection in mice by an effective  combination of oseltamivir and S-adenosyl-L-methionine (SAM). -J. Pharmacy and Nutrition Sciences 12:

     

    57. Hristova, N., A. S. Galabov (2023): Genus Simplexvirus: life cycle.- Acta Microbiologica Bulgarica. 39:16-22

     

    58. Hristova, N., A. S. Galabov (2023): Pathogenesis, diseases, immune response and chemotherapy of genus Simplexvirus. – Acta Microbiologica Bulgarica 39: 102-110.

     

    59. Stoyanova, A., A. Popatanasov, V. Rashev, L. Tancheva, S. Quideau, A. S. Galabov (2023): Effect of castalagin against HSV-1 infection in newborn mice. – Natural Product Research 37: 4156-4161. GNPL#2173191

     

    60.. Galabov, A. S., A. Stoyanova, S. A. Galabov (2023): Терапия на ентеровирусните инфекции.- Природа 2023/2: 14-19

     

    61. Гълъбов, А. С., Хр. Найденски (2023): История на Института по микробиология „Стефан Ангелов“ при  БАН и предизвикателствата към него през XXI век. - Списание на  БАН 136, 5/2023: 37-47

     

    62. Stoyanova, A., S. A. Galabov, N. Hristova, V. Makarov, A. S. Galabov (2023):  Antiviral effect of triple combination of VP1 ligsnds against Coxsackievirus B3 in newborn mice. - Acta Microbiol. Bulg. 39: 386-391.

     

    63. Ianevski, A., I.T. Frøysa, Hilde 39525; C. Calitz, T. Smura, H.-J. Schjelderup Nilsen, E. Høyer, J.. E. Afset,  A.Sridhar, K. C. Wolthers, E. Zusinaite, T. Tension, R. Kurg, V. Oksenych, A. S. Galabov, A. Stoyanova, M. Bjørås, D. Kainov (2024): The combination of pleconaril, rupintrivir, and remdesivir efficiently inhibits enterovirus infections in vitro, delaying the development of drug-resistant virus variants. - Antiviral Research 224. 105842.

     

    64. Витанов, П., M. Христов, И. Димов, A. С. Гълъбов (2024): Българският принос в третата индустриална революция. - Списание на БАН  155/2: 15-20.

     

    65. Stoyanova, A., S. Galabov, A. S. Galabov (2024): Antiviral activity in vitro of double combinations of enteroviral inhibitors. - Acta Virologica. Frontierspartnerships.org.

     
    More Info.
    Farsang Attila
    Project Manager
    Virologist
    Leading of Molecular Biological Laboratory
    Hungary
    AAA

    Research Interest: Vaccine, Vaccinology, HIV, gp41, Animal Trials



    More Info.
    Pramod Kumar
    Head
    Department of Dermatology G.U.M
    Saham Hospital
    Oman
    AAA

    Research Interest: Paediatric Dermatology, Contact and Occupational Dermatoses, Clinical Dermatology, Experimental Dermatology and Dermatosurgery.


    More Info.
    Christophe Vanpouille
    Staff Scientist
    Intercellular Interactions NICHD, NIH
    France
    AAA

    Research Interest: HIV-1, Antivirals,Tissue; Ex Vivo, Pathogens.


    More Info.
    A P Malyshkin
    Head
    Division of Laboratory Diagnosis Orenburg Regional Tuberculosis Control Center
    Russia
    AAA

    Research Interest: Microbiology, Immunology, Infectious Diseases and Their Prevention.



    More Info.
    Marina K. Kukhanova
    Professor
    Molecular Biology
    Institute of Russian Academy of Sciences
    Russia
    AAA

    Research Interest: Viral replication, antiviral and anticancer drug development, mechanism of action of potential antiviral compounds, cellular metabolism and toxicity, pharmacokinetics, enzymology, kinetics.

    More Info.
    Vykuntaraju K N Gowda
    Assistant Professor
    Pediatric Neurology Indira Gandhi Institute of Child Health
    India
    AAA

    Research Interest: Pediatric Epilepsy, Neuroinfections and Para Infectious Disorders, Developmental Neurology, Cerebral Palsy




    More Info.
    View more
    mendeley

    Analysis of baseline laboratory characteristics of HIV-positive patients in Bulgaria treated with bictegravir /emtricitabine/ tenofovir anafelamide (early analysis)

    DOI Logo 10.17352/aaa.000018

    Published On: January 04, 2024 | Pages: 001 - 007

    Author(s): Dimitar Strashimirov*, Ralitsa Yordanova, Rusina Grozdeva, Evgeni Penchev, Daniel Ivanov and Nina Yancheva-Petrova

    ORCID Logo  0000-0001-9053-6949

    Abstract View Full Article View
    mendeley

    Clinical presentation, ICU management and outcome in severe COVID-19 disease – A prospective observational study

    DOI Logo 10.17352/aaa.000017

    Published On: June 13, 2023 | Pages: 010 - 016

    Author(s): Prakash Shastri*
    Abstract View Full Article View
    mendeley

    A comprehensive overview of the pharmaceutical properties of Indian coastal sand dune flora: Emphasis on anti-virals

    DOI Logo 10.17352/aaa.000016

    Published On: February 03, 2023 | Pages: 001 - 009

    Author(s): Saravanakumar Vigneshwar, Arjun Kowsalya, Sarah Jency John Kennedy, Praveen Gopi and Dinakarkumar Yuvaraj*

    ORCID Logo  0000-0001-7579-4157

    Abstract View Full Article View    
    mendeley

    Selenium supplementation in the prevention of coronavirus infections* (*In Memory of Laszlo G. Egyud)

    DOI Logo 10.17352/aaa.000015

    Published On: April 06, 2022 | Pages: 001 - 003

    Author(s): Boguslaw Lipinski*
    Abstract View Full Article View    
    mendeley

    Case study – apply a deep-learning algorithm to exomes detection with online resources

    DOI Logo 10.17352/aaa.000014

    Published On: December 24, 2021 | Pages: 033 - 035

    Author(s): Maria da Conceição Proença* and António Pedro Alves de Matos
    Abstract View Full Article View    
    mendeley

    Molecular Docking studies on the Anti-fungal activity of Allium sativum (Garlic) against Mucormycosis (black fungus) by BIOVIA discovery studio visualizer 21.1.0.0

    DOI Logo 10.17352/aaa.000013

    Published On: November 12, 2021 | Pages: 028 - 032

    Author(s): Shaweta Sharma*, Akhil Sharma and Utsav Gupta
    Abstract View Full Article View    
    mendeley

    Socio-demographic characteristics influencing knowledge, attitude and preventive practices of COVID-19 among Ghanaians: A cross-sectional study

    DOI Logo 10.17352/aaa.000012

    Published On: November 12, 2021 | Pages: 019 - 027

    Author(s): Philip Apraku Tawiah*, Kingsley Arhin-Wiredu, Kwabena Oppong, Bernard Nii Torgbor, Phenehance Effah Konadu and Albert Abaka-Yawson
    Abstract View Full Article View    
    mendeley

    Bromelain: A potential therapeutic application in SARS-CoV-2 infected patients

    DOI Logo 10.17352/aaa.000011

    Published On: June 19, 2021 | Pages: 015 - 018

    Author(s): Serkan Sayıner, Ayliz Velioğlu-Öğünç and Ahmet Özer Şehirli*
    Abstract View Full Article View    
    mendeley

    A combination treatment of IFN-α2b and IFN-γ accelerates viral clearance and control inflammatory response in COVID-19: Preliminary results of a randomized controlled trial

    DOI Logo 10.17352/aaa.000010

    Published On: June 15, 2021 | Pages: 001 - 014

    Author(s): Esquivel-Moynelo Idelsis, Pérez-Escribano Jésus, Duncan-Roberts Yaquelin, Vázquez-Blomquist Dania, Bequet-Romero Mónica, Báez-Rodríguez Lisandra, Castro-Ríos Jésus, Cobas-Cervantes Lisbeth, Pagé-Calvet Ernesto, Travieso-Pérez Saily, Martinez-Suarez Claudia, Campa-Legra Ivan, Fernandez-Masso Julio, Camacho-Rodriguez Hamlet, Díaz-Gálvez Marisol, Sin-Mayor Adriana, García-Sánchez Maura, Martínez-Martín Sara, Alonso-Valdés Marel, Hernández-Bernal Francisco, Nodarse-Cuni Hugo, Bello-Garcia Dianela, Canaan-Haden Ayala Camila, Gonzáles-Moya Isabel, Beato-Canfuk Abrahan, Vizcaino-Cesar Tania, Guillén-Nieto Gerardo, Muzio-González Verena, Fish Eleanor and Bello-Rivero Iraldo*
    Abstract View Full Article View    
    mendeley

    Apheresis Procedure could Prevent Sequele of Hsv1 Encephalitis-Case Report

    DOI Logo 10.17352/aaa.000009

    Published On: May 30, 2020 | Pages: 010 - 013

    Author(s): Vjeroslava Slavic*
    Abstract View Full Article View    

     

    Indexing/Archiving